| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2022 | SUNOMIX THERAPEUTICS | 7625 HEATHERLY LN | SAN DIEGO | CA | 92130-5602 | SAN DIEGO | USA | R43IP001195 | mRNA-BASED VACCINE AGAINST MULTIPLE COVID-19 VARIANTS | 02 | 1 | CDC | 1/17/2024 | $0 |
| | 2024 | 2022 | SUNOMIX THERAPEUTICS | 7625 HEATHERLY LN | SAN DIEGO | CA | 92130-5602 | SAN DIEGO | USA | R43IP001195 | mRNA-BASED VACCINE AGAINST MULTIPLE COVID-19 VARIANTS | 03 | 1 | CDC | 2/15/2024 | $0 |
| | 2024 | 2022 | SUNOMIX THERAPEUTICS | 7625 HEATHERLY LN | SAN DIEGO | CA | 92130-5602 | SAN DIEGO | USA | R43IP001195 | mRNA-BASED VACCINE AGAINST MULTIPLE COVID-19 VARIANTS | 03 | 1 | CDC | 2/15/2024 | $0 |
| | 2024 | 2022 | SUNOMIX THERAPEUTICS | 7625 HEATHERLY LN | SAN DIEGO | CA | 92130-5602 | SAN DIEGO | USA | R43IP001195 | mRNA-BASED VACCINE AGAINST MULTIPLE COVID-19 VARIANTS | 02 | 1 | CDC | 1/17/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2022 | SUNOMIX THERAPEUTICS | 7625 HEATHERLY LN | SAN DIEGO | CA | 92130-5602 | SAN DIEGO | USA | R43IP001195 | mRNA-BASED VACCINE AGAINST MULTIPLE COVID-19 VARIANTS | 01 | 1 | CDC | 8/21/2023 | $0 |
| | 2023 | 2022 | SUNOMIX THERAPEUTICS | 7625 HEATHERLY LN | SAN DIEGO | CA | 92130-5602 | SAN DIEGO | USA | R43IP001195 | mRNA-BASED VACCINE AGAINST MULTIPLE COVID-19 VARIANTS | 01 | 1 | CDC | 8/21/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $252,010 ) |
| | 2022 | 2022 | SUNOMIX THERAPEUTICS | 7625 HEATHERLY LN | SAN DIEGO | CA | 92130-5602 | SAN DIEGO | USA | R43IP001195 | mRNA-BASED VACCINE AGAINST MULTIPLE COVID-19 VARIANTS | 00 | 1 | CDC | 9/1/2022 | $29,684 |
| | 2022 | 2022 | SUNOMIX THERAPEUTICS | 7625 HEATHERLY LN | SAN DIEGO | CA | 92130-5602 | SAN DIEGO | USA | R43IP001195 | mRNA-BASED VACCINE AGAINST MULTIPLE COVID-19 VARIANTS | 00 | 1 | CDC | 9/1/2022 | $222,326 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2018 | SUNOMIX THERAPEUTICS | 7625 HEATHERLY LN | SAN DIEGO | CA | 92130-5602 | SAN DIEGO | USA | R41AI138764 | A NOVEL SELF-ASSEMBLING PROTEIN NANOPARTICLES-BASED GENITAL HERPES VACCINE | 000 | 1 | NIH | 11/16/2020 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| | 2020 | 2018 | SUNOMIX THERAPEUTICS | 7625 HEATHERLY LN | SAN DIEGO | CA | 92130-5602 | SAN DIEGO | USA | R41AI138764 | A NOVEL SELF-ASSEMBLING PROTEIN NANOPARTICLES-BASED GENITAL HERPES VACCINE | 000 | 1 | NIH | 9/25/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $0 ) |
| | 2019 | 2018 | SUNOMIX THERAPEUTICS | 7625 HEATHERLY LN | SAN DIEGO | CA | 92130-5602 | SAN DIEGO | USA | R41AI138764 | A NOVEL SELF-ASSEMBLING PROTEIN NANOPARTICLES-BASED GENITAL HERPES VACCINE | 000 | 1 | NIH | 6/7/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $235,980 ) |
| | 2018 | 2018 | SUNOMIX THERAPEUTICS | 7625 HEATHERLY LN | SAN DIEGO | CA | 92130-5602 | SAN DIEGO | USA | R41AI138764 | A NOVEL SELF-ASSEMBLING PROTEIN NANOPARTICLES-BASED GENITAL HERPES VACCINE | 000 | 1 | NIH | 3/27/2018 | $235,980 |
|
|
